OnCusp Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Deals

16 June 2025

NextCure joins Merck in an ovarian target

But the former is paying a fraction of what Merck shelled out for raludotatug.

Deals Trial results

16 August 2023

Cautious support for targeting CDH6

Subscribe to OnCusp Therapeutics